The Effect of Zirconium Citrate on the Latent Period of Sr 89 -Induced Bone Cancer in Mice
A large cancerogenic dose of Sr89 was given intraperitoneally to virgin female CF1 mice. The tumor-inhibiting effect of zirconium citrate was determined by changes in the incidence and latent period of bone tumors. Early intraperitoneal administration of zirconium citrate after injection of Sr89 lengthened the latent period of osteogenic sarcoma, especially when repeated injections of zirconium citrate were given. Lowered incidence of tumors in some groups given zirconium citrate was not statistically significant.
- Research Organization:
- Marquette Univ., School of Medicine, Milwaukee
- Sponsoring Organization:
- USDOE
- NSA Number:
- NSA-14-023980
- OSTI ID:
- 4145032
- Journal Information:
- Radiation Research, Journal Name: Radiation Research Journal Issue: 3 Vol. 13; ISSN 0033-7587
- Publisher:
- Radiation Research Society
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Similar Records
CONCENTRATION OF STRONTIUM AT PREDILECTIVE SITES OF BONE TUMORS
STUDY OF LONG-TERM PATHOLOGIC EFFECTS OF RADIOACTIVE ISOTOPES OF CALCIUM AND STRONTIUM IN BONE AND SOFT TISSUES, ESPECIALLY WITH REFERENCE TO BONE TUMOR PRODUCTION. Final Technical Report for May 16, 1958-August 31, 1959
CONCENTRATION OF Sr$sup 89$ IN COMMON BONE TUMOR SITES
Journal Article
·
Sat Sep 01 00:00:00 EDT 1962
· Laboratory Investigation (U.S.)
·
OSTI ID:4768607
STUDY OF LONG-TERM PATHOLOGIC EFFECTS OF RADIOACTIVE ISOTOPES OF CALCIUM AND STRONTIUM IN BONE AND SOFT TISSUES, ESPECIALLY WITH REFERENCE TO BONE TUMOR PRODUCTION. Final Technical Report for May 16, 1958-August 31, 1959
Technical Report
·
Sun Oct 30 23:00:00 EST 1960
·
OSTI ID:4239403
CONCENTRATION OF Sr$sup 89$ IN COMMON BONE TUMOR SITES
Journal Article
·
Wed Aug 01 00:00:00 EDT 1962
· J. Lab. Invest.
·
OSTI ID:4780511